Biocon Biologics Gets Licence from Adagio Therapeutics for Antibody Treatment of Covid-19

Monday, July 26, 2021

via Top India News- News18.com
https://ift.tt/3eXZuzW
Adagio Therapeutics has granted an exclusive licence to the company to manufacture and commercialise an antibody treatment based on ADG20 for India and select emerging markets.
July 26, 2021 at 10:33PM
Top India News- News18.com
https://ift.tt/2xHgTtr
Adagio Therapeutics has granted an exclusive licence to the company to manufacture and commercialise an antibody treatment based on ADG20 for India and select emerging markets.
Biocon Biologics Gets Licence from Adagio Therapeutics for Antibody Treatment of Covid-19
Tags:

Post a Comment

0 Comments

Post a Comment
data-aa="1781698" src="//ad.a-ads.com/1781698?size=300x250" style="width:300px; height:250px; border:0px; padding:0; overflow:hidden; background-color: transparent;" >